Literature DB >> 16785797

Morphologic, immunologic, and molecular methods to detect bacillus anthracis in formalin-fixed tissues.

Kathleen M Tatti1, Patricia Greer, Elizabeth White, Wun-Ju Shieh, Jeannette Guarner, Tara Ferebee-Harris, Jeanine Bartlett, David Ashford, Alex Hoffmaster, George Gallucci, Abbas Vafai, Tanja Popovic, Sherif R Zaki.   

Abstract

Due to the importance of Bacillus anthracis as a cause of naturally occurring infection among humans and as an agent of bioterrorism, there is a vital need for rapid and specific assays, including immunohistochemistry (IHC) and polymerase chain reaction (PCR) assays, to detect the bacterium in formalin-fixed tissues. Colorimetric IHC assays were developed using a multistep indirect immunoalkaline phosphatase method with anti-B. anthracis cell wall (EAII-6G6-2-3) and anti-B. anthracis capsule (FDF-1B9) mAbs to detect B. anthracis antigens in formalin-fixed, paraffin-embedded bacterial cultures and tissues. B. anthracis antigens were localized, using both antibodies, in samples from B. anthracis-infected animals and humans. The colorimetric IHC assay with both antibodies was expedient in diagnosing the presence of B. anthracis in formalin-fixed, paraffin-embedded tissue from bioterrorism-associated cases of inhalational and cutaneous anthrax and from a case of naturally occurring cutaneous anthrax. Using the same antibodies, confocal microscopy demonstrated the structure of replicating B. anthracis in tissues. B. anthracis-specific primers were successfully used with PCR to amplify and detect B. anthracis sequences derived from formalin-fixed tissues of anthrax cases. In this study, morphologic, immunologic, and molecular assays were used to study and diagnose 22 veterinary and human anthrax cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785797     DOI: 10.1097/01.pai.0000178390.39047.78

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  4 in total

1.  Rapid Presumptive Identification of Bacillus anthracis Isolates Using the Tetracore RedLine Alert™ Test.

Authors:  Segaran P Pillai; Kristin W Prentice; Jason G Ramage; Lindsay DePalma; Jawad Sarwar; Nishanth Parameswaran; Melissa Bell; Andrea Plummer; Alan Santos; Ajay Singh; Christine A Pillai; Nagarajan Thirunavvukarasu; Gowri Manickam; Julie R Avila; Shashi K Sharma; Alex Hoffmaster; Kevin Anderson; Stephen A Morse; Kodumudi Venkat Venkateswaran; David R Hodge
Journal:  Health Secur       Date:  2019 Jul/Aug

2.  Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.

Authors:  Nicholas J Vietri; Steven A Tobery; Donald J Chabot; Susham Ingavale; Brandon C Somerville; Jeremy A Miller; Chris W Schellhase; Nancy A Twenhafel; David P Fetterer; Christopher K Cote; Christopher P Klimko; Anne E Boyer; Adrian R Woolfitt; John R Barr; Mary E Wright; Arthur M Friedlander
Journal:  J Infect Dis       Date:  2021-02-03       Impact factor: 5.226

3.  Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.

Authors:  Anne E Boyer; Conrad P Quinn; Cari A Beesley; Maribel Gallegos-Candela; Chung K Marston; Li X Cronin; Renato C Lins; Robyn A Stoddard; Han Li; Jarad Schiffer; M Jahangir Hossain; Apurba Chakraborty; Mahmudur Rahman; Stephen P Luby; Wun-Ju Shieh; Sherif Zaki; John R Barr; Alex R Hoffmaster
Journal:  J Infect Dis       Date:  2011-09-09       Impact factor: 5.226

4.  Serum adenosine deaminase activity in cutaneous anthrax.

Authors:  Mahmut Sunnetcioglu; Sevdegul Karadas; Mehmet Aslan; Mehmet Resat Ceylan; Halit Demir; Mehmet Resit Oncu; Mustafa Kasım Karahocagil; Aysel Sunnetcioglu; Cenk Aypak
Journal:  Med Sci Monit       Date:  2014-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.